Abstract
The recent advances of PET using biomolecules, such as peptides, monoclonal antibodies, oligonucleotides, and glycoproteins will be described. So far, PET of biomolecules has been used mainly for diagnosis of cancers. The biomolecules have been conjugated with DOTA ligand, labeled with radiometals as the β+ emitter, and targeted to specific tumors, where they have enabled visualization of even small metastatic lesions, due to the high sensitivity of the PET scanners.
Keywords: Positron emission tomography (PET), β+ emitter, biomolecule, tumor, diagnosis, DOTA
Mini-Reviews in Organic Chemistry
Title: Recent Advances in Positron Emission Tomography (PET) Imaging of Biomolecules: From Chemical Labeling to Cancer Diagnostics
Volume: 5 Issue: 3
Author(s): Katsunori Tanaka and Koichi Fukase
Affiliation:
Keywords: Positron emission tomography (PET), β+ emitter, biomolecule, tumor, diagnosis, DOTA
Abstract: The recent advances of PET using biomolecules, such as peptides, monoclonal antibodies, oligonucleotides, and glycoproteins will be described. So far, PET of biomolecules has been used mainly for diagnosis of cancers. The biomolecules have been conjugated with DOTA ligand, labeled with radiometals as the β+ emitter, and targeted to specific tumors, where they have enabled visualization of even small metastatic lesions, due to the high sensitivity of the PET scanners.
Export Options
About this article
Cite this article as:
Tanaka Katsunori and Fukase Koichi, Recent Advances in Positron Emission Tomography (PET) Imaging of Biomolecules: From Chemical Labeling to Cancer Diagnostics, Mini-Reviews in Organic Chemistry 2008; 5 (3) . https://dx.doi.org/10.2174/157019308785161684
DOI https://dx.doi.org/10.2174/157019308785161684 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Advances in Non-Steroidal FXR Antagonists Development for Therapeutic Applications
Current Topics in Medicinal Chemistry The Application of Rational Design on Phospholipase A2 Inhibitors
Current Medicinal Chemistry An Insight into Anticancer Bioactives from <i>Punica granatum</i> (Pomegranate)
Anti-Cancer Agents in Medicinal Chemistry MicroRNAs (miRNAs) as Biomarker(s) for Prognosis and Diagnosis of Gastrointestinal (GI) Cancers
Current Pharmaceutical Design A Case of Quinacrine-induced Psychosis: Case Report
Current Drug Safety Novel Approaches to the Pharmacotherapy of Obesity
Current Pharmaceutical Design Inhibition of Early Upstream Events in Prodromal Alzheimer’s Disease by Use of Targeted Antioxidants
Current Aging Science Aptamers as Therapeutics in Cardiovascular Diseases
Current Medicinal Chemistry Inflammatory Cytokines, Growth Factors, and Depression
Current Pharmaceutical Design Therapeutics Based on microRNA: A New Approach for Liver Cancer
Current Genomics Statins as Either Immunomodulators or Anti-Cancer Drugs: Functional Activities on Tumor Stromal Cells and Natural Killer Cells
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry A Novel Hydroxysteroid-Sulfating Cytosolic Sulfotransferase, SULT3 ST3, from Zebrafish: Identification, Characterization, and Ontogenic Study
Drug Metabolism Letters The Therapeutic use of the Zonulin Inhibitor AT-1001 (Larazotide) for a Variety of Acute and Chronic Inflammatory Diseases
Current Medicinal Chemistry Hypothyroidism and Endothelial Function: A Marker of Early Atherosclerosis?
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Blocking the PI3K/PKB Pathway in Tumor Cells
Current Medicinal Chemistry - Anti-Cancer Agents Polymorphism in Endothelin-1 Gene: An Overview
Current Clinical Pharmacology Impact of SINEs and LINEs on the Mammalian Genome
Current Genomics Animal Models of Xenobiotic Receptors
Current Drug Metabolism <i>Prunella vulgaris</i> L: Critical Pharmacological, Expository Traditional Uses and Extensive Phytochemistry: A Review
Current Drug Discovery Technologies Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/ Refractory Diffuse Large B Cell Lymphoma
Current Stem Cell Research & Therapy